throbber
Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA522251
`ESTTA Tracking number:
`02/19/2013
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`Notice of Opposition
`
`Notice is hereby given that the following party opposes registration of the indicated application.
`Opposer Information
`
`Name
`Granted to Date
`of previous
`extension
`Address
`
`Novartis AG
`02/17/2013
`
`CH4002
`Basel,
`SWITZERLAND
`
`Attorney
`information
`
`Craig S. Mende
`Fross Zelnick Lehrman & Zissu, P.C.
`866 United Nations Plaza
`New York, NY 10017
`UNITED STATES
`cmende@fzlz.com,ghuron@fzlz.com Phone:2128135900
`Applicant Information
`
`Application No
`Opposition Filing
`Date
`Applicant
`
`85638848
`02/19/2013
`
`Publication date
`Opposition
`Period Ends
`
`08/21/2012
`02/17/2013
`
`Alpha Helix Inc.
`Suite 3206 3750 Las Vegas Blvd
`Las Vegas, NV 89158
`UNITED STATES
`Goods/Services Affected by Opposition
`
`Class 005.
`All goods and services in the class are opposed, namely: Dietary supplements for boosting pre-
`workout energy; Nutritional supplements for boosting pre-workout energy
`
`Grounds for Opposition
`
`Priority and likelihood of confusion
`Dilution
`
`Trademark Act section 2(d)
`Trademark Act section 43(c)
`
`Marks Cited by Opposer as Basis for Opposition
`
`U.S. Registration
`No.
`Registration Date
`
`3767722
`
`03/30/2010
`
`Word Mark
`
`VOLTAREN
`
`Application Date
`
`07/10/2009
`
`Foreign Priority
`Date
`
`NONE
`
`

`
`Design Mark
`
`Description of
`Mark
`Goods/Services
`
`U.S. Registration
`No.
`Registration Date
`
`Word Mark
`Design Mark
`Description of
`Mark
`Goods/Services
`
`NONE
`
`Class 005. First use:
`Pharmaceutical preparations, namely, anti-inflammatory preparations and
`analgesics
`
`960282
`
`06/05/1973
`
`VOLTAREN
`
`NONE
`
`Application Date
`
`04/28/1972
`
`Foreign Priority
`Date
`
`NONE
`
`Class U018 (International Class 005). First use:
`ANTIPHLOGISTIC AND ANTIRHEUMATIC
`
`Attachments
`
`79072252#TMSN.jpeg ( 1 page )( bytes )
`Notice of Opposition Novartis AG v. Alpha Helix (VOLTAREN v. VOLTAGEN)
`(F1175063).PDF ( 23 pages )(805791 bytes )
`
`The undersigned hereby certifies that a copy of this paper has been served upon all parties, at their address
`record by First Class Mail on this date.
`
`Certificate of Service
`
`Signature
`Name
`Date
`
`/Craig S. Mende/
`Craig S. Mende
`02/19/2013
`
`

`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`
`
`Opposition No.
`
`NOTICE OF OPPOSITION
`
`---------------------------------------------------------------x
`Novartis AG,
`
`
`
`
`:
`
`
`
`
`
`
`
`:
`
`
`
`Opposer,
`
`
`:
`
`
`
`
`
`
`
`:
`
`- against -
`
`
`
`
`:
`
`
`
`
`
`
`
`:
`Alpha Helix Inc.,
`
`
`
`
`:
`
`
`
`
`
`
`
`:
`
`
`
`Applicant.
`
`
`:
`---------------------------------------------------------------x
`
`
`Opposer Novartis AG, a Swiss corporation with a principal business address of CH 4002,
`
`Basel, Switzerland, believes that it would be damaged by the issuance of a registration for the
`
`trademark VOLTAGEN as applied for in intent-to-use Application Serial No. 85638848 (the
`
`“Application”) filed on May 30, 2012 by Alpha Helix Inc. (“Applicant”), and therefore opposes
`
`the same. The specific grounds for this opposition are as follows:
`
`
`
`FACTS
`
`A.
`
`
`Opposer and Its Famous VOLTAREN Mark
`
`1.
`
`Opposer and its predecessors-in-interest have used the mark VOLTAREN for
`
`many years in connection with healthcare products, including anti-inflammatory and pain relief
`
`products, throughout the United States.
`
`2.
`
`Through significant expenditures of time, effort and money promoting Opposer’s
`
`VOLTAREN mark and the associated logo (the “VOLTAREN mark”) and the products sold
`
`thereunder, as well as the success of VOLTAREN products in the marketplace over many years,
`
`{F1138365.3 }
`
`

`
`Opposer’s VOLTAREN mark has come to identify Opposer’s goods exclusively and uniquely,
`
`has become a well-known and famous mark of Opposer, and represents an enormous goodwill.
`
`3.
`
`Opposer Novartis A.G. and (under Opposer’s authorization) its U.S. subsidiary
`
`Novartis Corporation (together, “Novartis”) also own federal registrations for the VOLTAREN
`
`mark:
`
`I U.S. Reg. No. 3767722 for VOLTAREN & Design for “Pharmaceutical
`preparations, namely, anti-inflammatory preparations and analgesics” in
`International Class 5, issued in 2010; and
`
`0 U.S. Reg. No. 0960282 for VOLTAREN for “Antiphlogistic and antirheumatic”
`in International Class 5, issued in 1973.
`
`Print-outs from the United States Patent and Trademark Office’s database showing the title and
`
`status of these registrations are attached at Exhibit A. These registrations are valid, subsisting
`
`and in full force and effect, and constitute evidence of the validity of the marks shown therein
`
`and of Novartis’ exclusive right to use the marks in connection with the goods identified in the
`
`registrations.‘
`
`B.
`
`Applicant’s Application for VOLTAGEN
`
`4.
`
`Upon information and belief, Applicant is a Nevada corporation located and doing
`
`business at Suite 3206, 3750 Las Vegas Blvd., Las Vegas, NV 89158.
`
`5.
`
`Upon information and beliefi on May 30, 2012, long after Novartis’ VOLTAREN
`
`mark was first used in commerce, and long after Novartis’ VOLTAREN mark became famous
`
`and came to identify the goods of Novartis and its predecessors exclusively, Applicant filed the
`
`1 U.S. Reg. No. 0960282, owned by Novartis Corporation, has become incontestable and
`therefore constitutes conclusive evidence of the validity of the mark shown therein and of the
`exclusive right to use the VOLTAREN mark in connection with the goods identified in the
`registration.
`
`{F} 138365 3 }
`
`

`
`Application to register the mark VOLTAGEN for “Dietary supplements for boosting pre-workout
`
`energy; Nutritional supplements for boosting pre-workout energy” in International Class 5.
`
`6.
`
`Upon information and belief, Applicant did not begin selling products bearing the
`
`VOLTAGEN mark in the United States until the Summer of 2012.
`
`7.
`
`Applicant’s VOLTAGEN mark is highly similar to Novartis’ VOLTAREN mark
`
`in sight, sound and commercial impression. In fact, the only difference between VOLTAREN
`
`and VOLTAGEN is the substitution of one letter (a “G” for an “R”) within the eight letters in
`
`each mark.
`
`8.
`
`The goods identified in the Application for the VOLTAGEN mark are in the same
`
`international class and are related to the healthcare products sold under Novartis’ VOLTAREN
`
`mark.
`
`9.
`
`Upon information and belief, Applicant’s VOLTAGEN products are being and/or
`
`will be sold by the same types of retailers, including pharmacies, at which Novartis’
`
`VOLTAREN products are sold.
`
`10.
`
`Applicant has also copied additional indicia associated with the VOLTAREN
`
`mark and products, including by use of VOLTAGEN product packaging featuring the color
`
`orange, which is similar to the coloring of Novartis’ VOLTAREN packaging.
`
`l 1.
`
`In View of the similarities of the parties’ respective marks, goods and trade
`
`channels, Applicant’s use of the VOLTAGEN mark in connection with the goods identified in
`
`the Application is likely to cause confusion and/or mistake as to the source or sponsorship of
`
`those goods, including by deceiving consumers into believing that Applicant’s goods come from,
`
`or are approved by, the maker of products sold under the VOLTAREN mark.
`
`(F11383653 )
`
`

`
`12. When Applicant filed the Application to register the VOLTAGEN mark, it was on
`
`constructive notice of Novartis’ prior and exclusive rights in the VOLTAREN mark by virtue of
`
`Novartis’ federal trademark registrations therefor, pursuant to Section 22 of the Lanham Act, 15
`
`U.S.C. § 1072.
`
`13.
`
`Upon information and belief, when Applicant filed the Application to register the
`
`VOLTAGEN mark, it had actual knowledge of the prior use of the VOLTAREN mark in
`
`connection with the goods offered by Novartis and its predecessors-in-interest.
`
`14.
`
`Registration to Applicant of the VOLTAGEN mark would be inconsistent with
`
`Novartis’ prior exclusive rights in the VOLTAREN mark, would threaten destruction of
`
`Novartis’ investment and goodwill in its long-established and valuable VOLTAREN mark, and
`
`would dilute and impair the distinctiveness of Novartis’ famous VOLTAREN mark and the
`
`ability of the VOLTAREN mark to identify the goods offered by Novartis under the
`
`VOLTAREN mark.
`
`LANHAM ACT SECTION 2(d) — LIKELIHOOD OF CONFUSION
`
`FIRST CLAIM FOR RELIEF
`
`15.
`
`Opposer incorporates by reference paragraphs 1 through 14 above.
`
`16.
`
`Opposer’s VOLTAREN mark has been used continuously since a date prior to any
`
`priority date upon which Applicant may rely with respect to its VOLTAGEN mark.
`
`17.
`
`Applicant’s VOLTAGEN mark is highly similar to Opposer’s VOLTAREN mark.
`
`18.
`
`Applicant’s goods to be offered under the VOLTAGEN mark are closely related
`
`to goods sold under Opposer’s VOLTREN mark and, upon information and belief, will be sold to
`
`the same customers or types of customers to whom Opposer’s goods are sold under the
`
`VOLTAREN mark.
`
`{FH38365 3}
`
`

`
`19.
`
`Based on the similarity of the marks and goods, consumers are likely to be
`
`confused and/or deceived into falsely believing that the goods offered by Applicant under the
`
`VOLTAGEN mark originate with or are approved or authorized by the maker of VOLTAREN
`
`products, or that there is some relationship between Applicant and Opposer or the goods of
`
`Applicant sold under the VOLTAGEN mark and the goods of Opposer sold under the
`
`VOLTAREN mark. Any use of the VOLTAGEN mark by Applicant in connection with the
`
`goods identified in the Application is therefore likely to cause confusion, cause mistake, or to
`
`deceive consumers in violation of Section 2(d) of the Lanham Act, 15 U.S.C. § l052(d).
`
`20.
`
`By reason of the foregoing, Opposer will be damaged by the registration of the
`
`VOLTAGEN mark to Applicant.
`
`SECOND CLAIM FOR RELIEF
`
`LANHAM ACT SECTION 43§c) — DILUTION
`
`21.
`
`Opposer incorporates by reference paragraphs 1 through 20 above.
`
`22.
`
`Opposer’s VOLTAREN mark is federally-registered, distinctive, used nationally
`
`in commerce and promoted throughout the United States for many years, and is instantly
`
`recognized by consumers as a symbol of Opposer or its goods.
`
`23.
`
`Since long before any priority date upon which Applicant may rely, Opposer’s
`
`VOLTAREN mark has become famous.
`
`24.
`
`Applicant’s use and registration of the VOLTAGEN mark will damage Opposer
`
`by trading on the enormous goodwill and reputation associated with Opposer’s VOLTAREN
`
`mark and diluting its distinctiveness and ability to identify the goods offered by Opposer.
`
`[F1138365 3 )
`
`

`
`25.
`
`Thus, Applicant’s use and registration of the VOLTAGEN mark in connection
`
`with the goods identified in the Application will cause dilution of Opposer’s VOLTAREN mark
`
`in violation of Sections 13(a) and 43(c) of the Lanham Act, 15 U.S.C. §§ l063(a), 1125(0).
`
`26.
`
`By reason of the foregoing, Opposer will be damaged by the registration of
`
`Applicant’s VOLTAGEN mark.
`
`WHEREFORE, it is respectfully requested that this opposition be sustained and that the
`
`registration sought by the Application be denied in its entirety.
`
`Dated: New York, New York
`February 19, 2013
`
`_
`Respectfully submitted,
`
`FROSS ZELNTCK LEHRMAN & ZISSU, P.C.
`
`Craig Mende (cmende@fzlz.com)
`Giselle C.W. Huron (ghuron@fzlz.com)
`866 United Nations Plaza
`
`New York, New York 10017
`Tel: (212) 813-5900
`Attorneys for Opposer Novartis AG
`
`(FH38365 3 }
`
`

`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on this 19th day of February, 2013, a true and correct copy of the
`foregoing NOTICE OF OPPOSITION was served by U.S. first class mail on App1icant’s
`counsel of record:
`
`TRAVIS TUNNELL
`ANDERSON DAILEY LLP
`
`2002 SUMIVHT BLVD STE 1250
`
`ATLANTA, GA 30319-6402
`
`Q H
`
`Giselle C.W. I--Iuron
`
`{F1 I38361] I
`
`

`
`EXHIBIT A
`
`

`
`Generated on 2013-02-19T11:52:28.316-05:00
`
`Generated on:
`
`This page was generated by TSDR on 2013-02-19 11:52:28 EST
`
`Mark:
`
`VOLTAREN
`
`v It
`
`'
`
`US Serial
`Number:
`
`79072252
`
`"'°P"°°“°“
`Filing Date:
`
`Jul 10 2009
`'
`’
`
`US Registration
`Number:
`
`3767722
`
`R°9“‘”‘_“°" Mar. 30,2010
`Date.
`
`Register:
`
`Principal
`
`Mark Type:
`
`Trademark
`
`Status:
`
`Registered. The registration date is used to determine when post-registration
`maintenance documents are due.
`
`Status Date:
`
`Mar. 30, 2010
`
`Publication
`Date:
`
`Jan. 12,2010
`
`Mark Literal
`Elements:
`
`VOLTAREN
`
`Standard
`Character Claim:
`
`No
`
`Mark Information
`
`Mark Drawing
`Type:
`
`3 — AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/
`LETTER(S)/NUMBER(S)
`
`Color(s) Claimed:
`
`Color is not claimed as a feature of the mark.
`
`Design Search
`code(5):
`
`02.01.33 - Stick figures;Grotesque men formed by letters, numbers, punctuation
`or geometric shapes
`04.07.03 - Geometric shapes forming a person;Person formed by geometric
`shapes;Geometric figures representing a person;Geometric figures or
`combinations of geometric figures representing a person
`26.01.21 - Circles that are totally or partially shaded.
`26.03.21 - Ovals that are completely or partially shaded
`26.17.09 - Bands, curved;Bars, curved;Curved line(s), band(s) or bar(s);Lines,
`curved
`
`Related Properties Information
`
`

`
`International
`
`Registration
`Number:
`
`1011414
`
`International
`Registration Date:
`
`1111' 10’ 2009
`
`
`Claimed Ownership 0960282
`of US Registrations:
`1753115 L696”
`
`Goods and Services
`
`Note:
`
`The following symbols indicate that the registrant/owner has amended the goods/services:
`
`o
`o
`
`o
`
`- Brackets [..] indicate deleted goods/services;
`- Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit
`of incontestability; and
`- Asterisks *..* identify additional (new) wording in the goods/services.
`
`For:
`
`Pharmaceutical preparations, namely, anti-inflammatory preparations and
`.
`analgesics
`
`International Class: 005 - Primary Class
`
`U.S Class:
`
`006, 018, 044, 046, 051, 052
`
`Class Status:
`
`ACTIVE
`
`Basis:
`
`66(a)
`
`Basis Information (Case Level)
`
`Filed Use:
`
`Filed ITU:
`
`Filed 44D:
`
`Filed 44E:
`
`No
`
`No
`
`No
`
`No
`
`Currently Use: No
`
`Amended Use: No
`
`Currently ITU: No
`
`Amended ITU: No
`
`Currently 44D: No
`
`Amended 44D: No
`
`Currently 44E: No
`
`Amended 44E: No
`
`Filed 66A:
`
`Yes
`
`Currently 66A: Yes
`
`Filed No Basis: No
`
`Currently No
`Basis:
`
`No
`
`Current Owner(s) Information
`
`Owner Name: Novartis AG
`
`CH-4002 Basel
`Owner Address: SWITZERLAND
`
`

`
`Legal Entity
`Type:
`
`CORPORATION
`
`State or Country
`Where
`
`Organized:
`
`SWITZERLAND
`
`Attorneylcorrespondence Information
`
`Attorney of Record
`
`Attorney Name:
`
`Maury M. Tepper, III
`
`Correspondent
`
`Correspondent
`NamelAddress:
`
`Maury M. Tepper, III
`Tepper & Eyster, PLLC
`3724 Benson Drive
`
`Raleigh, NORTH CAROLINA 27609
`UNITED STATES
`
`Phone:
`
`919-861-8903
`
`Fax:
`
`919-861-8913
`
`Correspondent e-
`mail:
`
`mte
`
`2
`
`_
`;
`2 @ -
`er
`tel law com
`
`Correspondent e-
`mall Authorized: No
`
`Domestic Representative - Not Found
`
`Prosecution History
`
`Date
`
`Description
`
`:L°n:::in9
`
`Jul. 22, 2010
`
`Jul. 22, 2010
`
`Jul. 01, 2010
`
`FINAL DISPOSITION NOTICE SENT TO IB
`
`FINAL DISPOSITION PROCESSED
`
`68359
`
`FINAL DISPOSITION NOTICE CREATED, TO BE SENT
`TO IB
`
`Mar. 30, 2010
`
`REGISTERED-PRINCIPAL REGISTER
`
`Jan. 12, 2010
`
`MAILED
`
`OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-
`
`Jan. 12, 2010
`
`PUBLISHED FOR OPPOSITION
`
`Dec. 08, 2009
`
`LAW OFFICE PUBLICATION REVIEW COMPLETED
`
`73797
`
`Dec. 08, 2009
`
`ASSIGNED TO LIE
`
`Nov. 19, 2009
`
`Nov. 17, 2009
`
`Nov. 17, 2009
`
`APPROVED FOR PUB - PRINCIPAL REGISTER
`
`TEAS/EMAIL CORRESPONDENCE ENTERED
`
`CORRESPONDENCE RECEIVED IN LAW OFFICE
`
`Nov. 17. 2009
`
`TEAS RESPONSE TO OFFICE ACTION RECEIVED
`
`73797
`
`88889
`
`88889
`
`

`
`Nov. 06, 2009
`
`REFUSAL PROCESSED BY IB
`
`Oct. 26, 2009
`
`Oct. 26, 2009
`
`Oct. 14, 2009
`
`ATTORNEY REVOKED AND/OR APPOINTED
`
`TEAS REVOKE/APPOINT ATTORNEY RECEIVED
`
`NON—FINAL ACTION MAILED - REFUSAL SENT TO IB
`
`Oct. 14, 2009
`
`REFUSAL PROCESSED BY MPU
`
`Oct. 14, 2009
`
`NON—FINAL ACTION (IB REFUSAL) PREPARED FOR
`REVIEW
`
`Oct. 13,2009
`
`NON—FINAL ACTION WRITTEN
`
`Oct. 09, 2009
`
`ASSIGNED TO EXAMINER
`
`Sep. 29, 2009
`
`Sep.25,2009
`
`Sep. 24, 2009
`
`APPLICATION FILING RECEIPT MAILED
`
`NEW APPLICATION OFFICE SUPPLIED DATA
`ENTERED IN TRAM
`
`SN ASSIGNED FOR SECT 66A APPL FROM IB
`
`67445
`
`76839
`
`76839
`
`International Registration Information (Section 66a)
`
`International
`
`Registration
`Number:
`
`1011414
`
`International
`Registration Date:
`
`Jul. 10,2009
`
`lntl. Registration
`Status:
`
`REQUEST FOR
`EXTENSION OF
`PROTECTION PROCESSED
`
`I Date P‘
`
`I
`
`gtatusz
`
`Sep. 24,2009
`
`Notification of
`
`Designation Date:
`
`Sep. 24,2009
`
`First Refusal Flag:
`
`Yes
`
`D t
`fA t
`t"
`3 ggteaigma '° Mar. 24,2011
`
`TM Staff and Location Information
`
`TM Staff Information - None
`
`File Location
`
`Current Location:
`
`PUBLICATION AND ISSUE
`SECTION
`
`Date in Location: Mar. 30, 2010
`
`

`
`Generated on 2013-02-19T11253113749-05:00
`
`Generated on:
`
`This page was generated by TSDR on 2013-02-19 11:53:13 EST
`
`Mark:
`
`VOLTAREN
`
`us Serial Number: 72422688
`
`A°P"°3‘a‘g} F‘""9 Apr. 28,1972
`
`Us Registration
`Number:
`
`960282
`
`Re istration Date‘
`9
`'
`
`Jun 05 1973
`'
`’
`
`Register:
`
`Principal
`
`Mark Type:
`
`Trademark
`
`Status:
`
`The registration has been renewed.
`
`Status Date:
`
`Aug. 04, 2003
`
`Mark Information
`
`Mark Literal
`Elements:
`
`VOLTAREN
`
`Standard
`Character Claim:
`
`No
`
`""""" °'°‘”"‘9
`Type:
`
`1 — TYPESET WORD(S) /LETTER(S) /NUMBER(S)
`
`Foreign Information
`
`Foreign Registration
`Number:
`
`172661
`
`Foreign
`Registration Date: Oct’ 28’ 1958
`
`Foreign
`App|icationIRegistration SVVITZERLAND
`Country:
`
`Goods and Services
`
`Note:
`
`The following symbols indicate that the registrant/owner has amended the goods/services:
`
`-
`o
`
`o
`
`- Brackets [..] indicate deleted goods/services;
`- Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit
`of incontestability; and
`- Asterisks *..* identify additional (new) wording in the goods/services.
`
`

`
`For:
`
`ANTIPHLOGISTIC AND ANTIRHEUMATIC
`
`International Class: 005
`
`U.S Class:
`
`018 - Primary Class
`
`Class Status:
`
`ACTIVE
`
`Basis:
`
`44(e)
`
`Basis Information (Case Level)
`
`Filed Use:
`
`Filed ITU:
`
`Filed 44D:
`
`No
`
`No
`
`No
`
`Currently Use: No
`
`Amended Use: No
`
`Currently ITU: No
`
`Amended ITU: No
`
`Currently 44D: No
`
`Amended 44D: N0
`
`Filed 44E:
`
`Yes
`
`Currently 44E: Yes
`
`Amended 44E: No
`
`Filed 66A:
`
`No
`
`Currently 66A: No
`
`Filed No Basis: No
`
`Currently No
`Basis:
`
`No
`
`Current Owner(s) Information
`
`Owner Name: NOVARTIS CORPORATION
`
`608 FIFTH AVENUE
`
`Owner Address: NEW YORK, NEW YORK 10020
`UNITED STATES
`
`Legal Entity
`Type:
`
`CORPORATION
`
`State or Country NEW YORK
`Where Organized:
`
`Attorneylcorrespondence Information
`
`Attorney of Record - None
`
`Correspondent
`
`correspondent
`NamelAddress:
`
`Maury M. Tepper, III
`Tepper & Eyster, PLLC
`3724 Benson Drive
`.
`Ra1e1gh, NORTH CAROLINA 27609
`UNITED STATES
`
`Phone:
`
`919-861-8903
`
`Fax:
`
`919-861-8913
`
`Correspondent e- mte ; I; er@tei”1aw_c0m
`mall:
`
`Correspondent e- Yes
`mall Authorized.
`
`Domestic Representative - Not Found
`
`

`
`Prosecution History
`
`Date
`
`Description
`
`Proceeding
`Number
`
`76293
`
`76293
`
`67826
`
`Jul. 20, 2011
`
`ASSIGNMENT OF OWNERSHIP NOT UPDATED
`AUTOMATICALLY
`
`Jul. 13, 2011
`
`AUTOMATICALLY
`
`ASSIGNMENT OF OWNERSHIP NOT UPDATED
`
`Dec. 22, 2010
`
`ASSIGNMENT OF OWNERSHIP NOT UPDATED
`AUTOMATICALLY
`
`Dec. 15, 2010
`
`ASSIGNMENT OF OWNERSHIP NOT UPDATED
`AUTOMATICALLY
`
`Feb. 18, 2010
`
`ASSIGNMENT OF OWNERSHIP NOT UPDATED
`AUTOMATICALLY
`
`Jan. 22, 2010
`
`REVIEW OF CORRESPONDENCE COMPLETE
`
`Jan. 22, 2010
`
`CASE ASSIGNED TO POST REGISTRATION
`PARALEGAL
`
`Dec. 02, 2009
`
`Jun. 17, 2009
`
`Sep. 02, 2008
`
`Dec. 04, 2004
`
`CASE ASSIGNED TO POST REGISTRATION
`PARALEGAL
`
`TEAS CHANGE OF CORRESPONDENCE RECEIVED
`
`CASE FILE IN TICRS
`
`TEAS CHANGE OF CORRESPONDENCE RECEIVED
`
`Nov. 18, 2004
`
`PAPER RECEIVED
`
`Aug. 04, 2003
`
`REGISTERED AND RENEWED (SECOND RENEWAL - 10
`
`YRS)
`
`Aug. 04, 2003
`
`REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9
`GRANTED
`
`May 22, 2003
`
`REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9
`FILED
`
`May 21, 2003
`
`Oct. 28, 1996
`
`Sep. 09, 1996
`
`Oct. 27, 1993
`
`TEAS SECTION 8 & 9 RECEIVED
`
`REGISTERED - SEC. 15 ACKNOWLEDGED
`
`REGISTERED - SEC. 15 AFFIDAVIT FILED
`
`REGISTERED AND RENEWED (FIRST RENEWAL — 10
`
`YRS)
`
`Sep. 07, 1993
`
`REGISTERED - SEC. 9 FILED/CHECK RECORD FOR
`SEC. 8
`
`

`
`Jun. 04, 1979
`
`REGISTERED - SEC. 8 (6-YR) ACCEPTED
`
`Maintenance Filings or Post Registration Information
`
`Aff'd
`'t
`f
`c°nti'nE‘;i Sse:
`
`-
`Sectlon 8 - Accepted
`
`Affidavit of
`lncontestability:
`
`.
`Secnon 15 ' Accepted
`
`Renewal Date:
`
`Jun. 05, 2003
`
`TM Staff and Location Information
`
`TM Staff Information - None
`
`File Location
`
`Current Location: SCANNING ON DEMAND
`
`Date in Location: Sep. 02, 2008
`
`Assignment Abstract of Title Information
`
`.T°‘a'
`Assignments:
`
`10
`
`Assignment 1 of 10
`
`Summary
`
`Registrant:
`
`CIBA-GEIGY LIMITED
`
`C
`
`_
`°""°V°"°°'
`
`CERTIFICATE FROM THE REGISTRY OF COMMERCE OF THE CANTON
`OF BASLE, SHOWING CHANGE OF NAME ENTERED OCT. 21, 1970.
`
`ReeIlFrame:
`
`0205/0123
`
`Pages:
`
`1
`
`Date Recorded: Apr. 06, 1971
`
`No Supporting Documents
`
`Assignor
`
`Name:
`
`CIBA LIMITED
`
`Execution Date: Mar. 29, 1971
`
`Legal Entity Type: UNKNOWN
`
`State or Country
`
`Where
`Organized:
`
`3°C Where Orgamzed
`u
`
`-
`
`Name:
`
`CIBA-GEIGY LIMITED
`
`Assignee
`
`Legal Entity Type: UNKNOWN
`
`State or Country
`Where
`
`-
`No Place Where Orgamzed
`
`

`
`Organized:
`
`Found
`
`Address:
`
`No Assignee Address Found
`
`Correspondent
`
`Correspondent
`Name:
`
`HARRY GOLDSMITH
`
`Correspondent
`Address:
`
`556 MORRIS AVE.
`
`SUMMIT, NJ 07901
`
`Domestic Representative - Not Found
`
`Assignment 2 of 10
`
`Conveyance:
`
`ASSIGNS THE ENTIRE INTEREST AND THE GOODWILL
`
`Ree|IFrame:
`
`0249/0418
`
`Pages:
`
`3
`
`Date Recorded:
`
`Mar. 13, 1974
`
`Supporting
`Documents:
`
`No Supporting Documents
`
`Name:
`
`CIBA-GEIGY LIMITED
`
`Execution Date: Jan. 23, 1974
`
`Assignor
`
`Legal Entity Type:
`
`CORPORATION
`
`State or Country
`Where
`
`Organized:
`
`SWITZERLAND
`
`Name:
`
`CIBA-GEIGY CORPORATION
`
`Assignee
`
`Legal Entity Type:
`
`CORPORATION
`
`State or Country
`Where
`
`NEW YORK
`
`Organized:
`
`Address:
`
`444 SAW MILL RIVER ROAD
`
`ARDSLEY, NEW YORK 10502
`
`Correspondent
`
`Correspondent
`Name:
`
`Correspondent
`Address:
`
`GEORGE M. DOHERTY
`
`444 SAW MILL RIVER ROAD
`
`ARDSLEY, NY 10502
`
`Domestic Representative - Not Found
`
`Assignment 3 of 10
`
`Conveyance:
`
`CHANGE OF NAME
`
`ReelIFrame:
`
`1873/0581
`
`Pages:
`
`

`
`Date Recorded: Mar. 12, 1999
`
`supporting
`Documents:
`
`assignment-tm—1873-0581.pdf
`
`CIBA-GEIGY
`Name: N Execution Date: Dec. 26, 1996
`
`Assignor
`
`Legal Entity Type: CORPORATION
`
`State or Country
`
`Where
`Organized:
`
`11:10 P2306 Where Orgamzed
`mm
`
`-
`
`Name:
`
`NOVARTIS CORPORATION
`
`Assignee
`
`Legal Entity Type: CORPORATION
`
`Ad“'°s5‘
`
`564 MORRIS AVNEUE
`SUMMIT NEW JERSEY 07901
`
`State or Country
`Where
`Organized:
`
`NEW YORK
`
`Correspondent
`
`°°"°"’°""°"‘ BARRY A SOLOMON
`Name:
`'
`
`NOVARTIS CORPORATION
`
`Correspondent
`Address:
`
`PATENT AND TRADEMARK DEPARTMENT
`564 MORRIS AVENUE
`
`SUMMIT, NJ 07901-1027
`
`Domestic Representative - Not Found
`
`Assignment 4 of 10
`
`Conveyance:
`
`CHANGE OF NAME
`
`ReellFrame:
`
`1900/0069
`
`Pages:
`
`11
`
`Date Recorded: Oct. 16, 1998
`
`5“PP°'“"9
`Documents:
`
`assignment-tm-1900-0069.pdf
`
`Assignor
`
`Name:
`
`CIBA-GEIGY
` ON
`
`Legal Entity Type: CORPORATION
`
`Execution Date: Dec. 26, 1996
`
`State or Country
`Where
`Organized:
`
`NEW YORK
`
`Name:
`
`NOVARTIS CORPORATION
`
`Assignee
`
`

`
`Legal Entity Type:
`
`CORPORATION
`
`State or Country
`Where
`
`NEW YORK
`
`Organized:
`
`Address:
`
`564 MORRIS AVENUE
`
`SUMMIT, NEW JERSEY 07901
`
`Correspondent
`
`Correspondent
`Name:
`
`NOVARTIS CORPORATION
`
`Correspondent
`Address:
`
`BARRY A. SOLOMON, ESQ.
`564 MORRIS AVENUE
`
`SUMMIT, NJ 07901
`
`Domestic Representative - Not Found
`
`Assignment 5 of 10
`
`Conveyance:
`
`LICENSE
`
`Ree|IFrame:
`
`4088/0466
`
`Date Recorded:
`
`Oct. 30, 2009
`
`Supporting
`Documents:
`
`assignment-tm-4088-0466.pdf
`
`Pages:
`
`Name:
`
`
`NOVARTIS AG
`
`Execution Date: Mar. 04, 2008
`
`Assignor
`
`Legal Entity Type:
`
`CORPORATION
`
`State or Country
`Where
`
`Organized:
`
`SWITZERLAND
`
`Name:
`
`NOVARTIS CONSUMER
` EALTHINC.
`
`
`_
`Execution Date. Mar. 04, 2008
`
`Legal Entity Type:
`
`CORPORATION
`
`State or Country
`Where
`
`Organized:
`
`NEW JERSEY
`
`Name:
`
`ENDO PHARMACEUTICALS INC.
`
`Assignee
`
`Legal Entity Type:
`
`CORPORATION
`
`State or Country
`Where
`
`Organized:
`
`PENNSYLVANIA
`
`Address:
`
`100 ENDO BOULEVARD
`
`CHADDS FORD, PENNSYLVANIA 19317
`
`Correspondent
`
`

`
`°°"°s"°"°'°"* GUY DONATIELLO
`Name:
`
`Correspondent
`Address:
`
`100 ENDO BOULEVARD
`CHADDS FORD, PA 19317
`
`Assignment 6 of 10
`
`Domestic Representative - Not Found
`
`C
`
`_
`°""°Va"°°'
`
`CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES
`TRADEMARKS (EXCLUSIVELY LICENSED TRADEMARKS)
`
`Reel/Frame:
`
`4149/0283
`
`Pages:
`
`6
`
`Date Recorded:
`
`Feb. 13,2010
`
`S”PP°'”"9
`Documents:
`
`assiggment-tm-4149-0283.pdf
`
`ENDO PHARMACEUTICALS
`Name: T“? Execution Date: Oct. 16, 2009
`INC.
`
`Assignor
`
`Legal Entity Type: CORPORATION
`
`State or Country
`Where
`Organized:
`
`DELAWARE
`
`Assignee
`
`Name:
`
`
`JPMORGAN CHASE BANK N.A. AS ADMINISTRATIVE AGENT
`
`Legal Entity Type:
`
`State or Country
`
`Where
`
`Organized:
`
`UNITED STATES
`
`Address.
`'
`
`10 SOUTH DEARBORN
`CHICAGO, ILLINOIS 60603
`
`Correspondent
`
`°°"°‘°'P°"“°"‘ DUSAN CLARK, ESQ.
`Name:
`
`C
`
`°'A'§:f:::°"‘
`'
`
`SIDLEY AUSTIN LLP
`717 N. HARWOOD ST., SUITE 3400
`DALLAS, TX 75201
`
`Assignment 7 of 10
`
`Domestic Representative - Not Found
`
`C
`
`_
`°""°V"‘"°°'
`
`CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES
`TRADEMARKS (EXCLUSIVELY LICENSED TRADEMARKS)
`
`ReellFrame:
`
`4423/0376
`
`Pages:
`
`7
`
`Date Recorded: Dec. 01, 2010
`
`

`
`Supporting
`Documents:
`
`assignment-tm—4423-O376.pdf
`
`Assignor
`
`Name:
`
` Execution Date: Nov. 30, 2010
`INC.
`
`Legal Entity Type:
`
`CORPORATION
`
`State or country
`Where
`
`Organized:
`
`DELAWARE
`
`Assignee
`
`Name:
`
`JPMORGAN CHASE BANK N.A. AS ADMINISTRATIVE AGENT
`
`Legal Entity Type:
`
`NATIONAL BANKING
`
`ASSOCATION
`
`s*““° °' °°"""V
`Where
`organized:
`
`UNITED STATES
`
`Address:
`
`10 SOUTH DEARBORN
`
`CHICAGO, ILLINOIS 60603
`
`Correspondent
`
`Correspondent
`Name:
`
`DUSAN CLARK, ESQ.
`
`Correspondent
`Address:
`
`SIDLEY AUSTIN LLP
`
`717 N. HARWOOD ST., SUITE 3400
`DALLAS, TX 75201
`
`Assignment 8 of 10
`
`Domestic Representative - Not Found
`
`Conveyance:
`
`RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME
`4149/283
`
`Reel/Frame:
`
`4428/0839
`
`Date Recorded:
`
`Dec. 09, 2010
`
`Pages:
`
`4
`
`Supporting
`Documents:
`
`assigggent-tm-4428-0839.pdf
`
`Assignor
`
`
`
`JPMORGAN CHASE BANK
`
`N.A. AS ADMINISTRATIVE Execution Date: Nov. 30, 2010
`AGENT
`
`Name:
`
`Legal Entity Type:
`
`NATIONAL ASSOCIATION
`
`State or Country
`Where
`
`Organized:
`
`UNITED STATES
`
`Name:
`
`ENDO PHARMACEUTICALS INC.
`
`Assignee
`
`

`
`Legal Entity Type: CORPORATION
`
`State or Country
`Where
`Organized:
`
`DELAWARE
`
`A°""°5s‘
`
`100 ENDO BLVD.
`CHADDS FORD, PENNSYLVANIA 19317
`
`Correspondent
`
`°°"°"°°""°"* DUSAN CLARK ESQ
`Name:
`’
`
`‘
`
`°°"°"°°"d°"‘
`Ad"'°ss‘
`
`SIDLEY AUSTIN LLP
`717 N HARWOOD ST SUITE 3400
`DALLAS, TX 75201
`
`Assignment 9 of 10
`
`Domestic Representative - Not Found
`
`Conveyance:
`
`SECURITY INTEREST IN EXCLUSIVELY LICENSED TRADEMARKS
`
`ReelIFrame:
`
`4577/0228
`
`Pages:
`
`6
`
`Date Recorded:
`
`Jul. 07, 2011
`
`aSsigT_1gent-tm-4577-O228.pdf
`
`Assignor
`
`Name: Execution Date:
`
`Jun. 17, 2011
`
`Legal Entity Type: CORPORATION
`
`State or Country
`Where
`Organized:
`
`DELAWARE
`
`Assignee
`
`Name_
`'
`
`
`MORGAN STANLEY SENIOR FUNDING INC. AS ADMINISTRATIVE
`AGENT
`
`Legal Entity Type: CORPORATION
`
`State or Country
`Where
`Organized:
`
`DELAWARE
`
`Address_
`
`1 PIERREPONT PLAZA
`BROOKLYN, NEW YORK 11201
`
`Correspondent
`
`°°"°‘P°"“°"‘ DUSAN CLARK, ESQ.
`Name:
`
`°°'A"‘;‘f::s"s“_°"‘
`'
`
`SIDLEY AUSTIN LLP
`717 N. HARWOOD ST., SUITE 3400
`DALLAS, TX 75201
`
`

`
`Assignment 10 of 10
`
`Domestic Representative - Not Found
`
`C
`
`_
`°""°V" "°°'
`
`RELEASE OF SECURITY INTEREST IN EXCLUSIVELY LICENSED
`TRADEMARKS RECORDED AT REEL/FRAME 4423/376
`
`ReelIFrame:
`
`4580/0431
`
`Pages:
`
`5
`
`Date Recorded:
`
`Jul. 12, 2011
`
`assignrnent-tm-4530-043 I .Qdf
`
`Assignor
`
`
`
`JPMORGAN CHASE BANK
`
`N.A. AS ADMINISTRATIVE Execution Date: Jun. 17, 2011
`AGENT
`
`Name:
`
`Legal Entity Type:
`
`NATIONAL BANKING
`
`ASSOCIATION
`
`State °' °°” "W
`Where
`organized:
`
`UNITED STATES
`
`Name:
`
`ENDO PHARMACEUTICALS INC.
`
`Assignee
`
`Legal Entity Type: CORPORATION
`
`State or Country
`Where
`Organized:
`
`DELAWARE
`
`Add
`
`_
`'°‘°“'
`
`100 ENDO BOULEVARD
`CHADDS FORD, PENNSYLVANIA 19317
`
`Correspondent
`
`°°"rj:fn°e':d°"‘ DUSAN CLARK, ESQ.
`
`°°;{§:f::s‘f°"‘
`'
`
`SIDLEY AUSTIN LLP
`717 N. HARWOOD ST., SUITE 3400
`DALLAS, TX 75201
`
`Domestic Representative - Not Found

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket